Alpa Laboratories Limited (BOM:532878)
India · Delayed Price · Currency is INR 63.03
+0.83 (1.33%)
At close: Aug 21, 2026
Alpa Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 150.1 | 195.03 | 167.77 | 125.83 | 140.92 |
Depreciation & Amortization | 20.92 | 22.02 | 19.55 | 13.29 | 16.57 |
Loss (Gain) From Sale of Investments | -119.64 | -164.6 | -100.47 | -33.01 | -88.34 |
Loss (Gain) on Equity Investments | - | - | - | 0 | -0.07 |
Provision & Write-off of Bad Debts | 5.2 | 8.53 | 4.06 | 6 | 5.35 |
Other Operating Activities | -30.52 | -0.63 | -13.84 | -15.04 | 10.45 |
Change in Accounts Receivable | 56.04 | -75.89 | 52.52 | -66.41 | 75.85 |
Change in Inventory | 43.07 | -39.74 | -10.24 | 28.22 | 10.96 |
Change in Accounts Payable | -9.03 | 203.95 | -37.07 | 19.81 | -81.96 |
Change in Other Net Operating Assets | -16.63 | 34.51 | -45.79 | 10.35 | 9.67 |
Operating Cash Flow | 99.5 | 183.18 | 36.49 | 89.04 | 99.4 |
Operating Cash Flow Growth | -45.68% | 402.05% | -59.02% | -10.42% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -39.54 | -113.8 | -63.85 | -11.26 | -21.91 |
Cash Acquisitions | - | - | - | -4.96 | 42.3 |
Investment in Securities | -103.48 | -33.94 | -95.14 | -0.29 | -191.76 |
Other Investing Activities | 27.45 | 24.11 | 25.63 | 37.78 | 15.27 |
Investing Cash Flow | -115.56 | -123.62 | -133.36 | 21.28 | -156.1 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 24.74 | - | 37.2 | - | 0.06 |
Long-Term Debt Issued | 0.07 | - | - | - | 56.55 |
Total Debt Issued | 24.8 | - | 37.2 | - | 56.62 |
Short-Term Debt Repaid | - | -52.12 | - | -0.26 | - |
Long-Term Debt Repaid | - | - | -7.77 | -35.43 | - |
Total Debt Repaid | - | -52.12 | -7.77 | -35.7 | - |
Net Debt Issued (Repaid) | 24.8 | -52.12 | 29.42 | -35.7 | 56.62 |
Other Financing Activities | -2.58 | -2.32 | -3.59 | -2.24 | -2.19 |
Financing Cash Flow | 22.22 | -54.44 | 25.83 | -37.93 | 54.43 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 6.16 | 5.12 | -71.04 | 72.39 | -2.27 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 59.97 | 69.39 | -27.37 | 77.78 | 77.49 |
Free Cash Flow Growth | -13.57% | - | - | 0.37% | - |
Free Cash Flow Margin | 5.67% | 6.17% | -2.52% | 8.37% | 6.90% |
Free Cash Flow Per Share | - | 3.30 | -1.30 | 3.70 | 3.68 |
Levered Free Cash Flow | 88.24 | 44.48 | -56.22 | 42.73 | 110.05 |
Unlevered Free Cash Flow | 89.85 | 45.92 | -53.98 | 43.25 | 110.72 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 2.58 | 2.32 | 3.59 | 2.24 | 2.19 |
Cash Income Tax Paid | 28.44 | 40.69 | 36.41 | 35.96 | 31.16 |
Change in Working Capital | 73.45 | 122.83 | -40.58 | -8.03 | 14.52 |